Programmed death-1 ligand 1 (PD-L1), which binds to the PD-1 receptor, is expressed in tumour and/or macrophage cells, whereas CD80, which binds to the CTLA-4 receptor, is expressed in dendritic cells (DCs)10. The gene discussed is CD80; the disease is neoplasm.